Familial breast cancer screening: ethical and social implicationsPARADISO, A; SCHITTULLI, F; SURBONE, A et al.Annals of oncology. 2004, Vol 15, issn 0923-7534, 70 p., SUP1Serial Issue

Genetic medicine: the balance between science and moralitySURBONE, A.Annals of oncology. 2004, Vol 15, pp 60-64, issn 0923-7534, 5 p., SUP1Article

MUC3 and MCA serum levels and steroid receptor content in breast cancerQUARANTA, M; COVIELLO, M; DANIELE, A et al.The International journal of biological markers. 2004, Vol 19, Num 2, pp 109-114, issn 0393-6155, 6 p.Article

Determination of free PSA in breast cancer cytosols by IRMAABBATE, I; MUSCI, M. D; PARADISO, A et al.The International journal of biological markers. 1996, Vol 11, Num 1, pp 53-54, issn 0393-6155Article

A prothrombotic state in breast cancer patients treated with adjuvant chemotherapyRELLA, C; COVIELLO, M; GIOTTA, F et al.Breast cancer research and treatment. 1996, Vol 40, Num 2, pp 151-159, issn 0167-6806Article

pS2-A new cytosolic protein recognized by monoclonal antibodies as a marker of hormone sensitivity in breast cancerCORREALE, M; ABBATE, I; PARADISO, A et al.Cell biophysics. 1993, Vol 22, Num 1-3, pp 101-110, issn 0163-4992Conference Paper

Costs and benefits of diagnosing familial breast cancerMØLLER, P.Annals of oncology. 2004, Vol 15, pp 55-59, issn 0923-7534, 5 p., SUP1Article

Intensive radiologic surveillance: a focus on the psychological issuesWARNER, E.Annals of oncology. 2004, Vol 15, pp i43-i47, issn 0923-7534, SUP1Article

MCA performance in preoperative breast cancer patientsDONADEO, A; MICELLI, G; QUARANTA, M et al.Anticancer research. 1995, Vol 15, Num 2, pp 527-529, issn 0250-7005Article

Decisions and outcomes of genetic testing for inherited breast cancer riskHALBERT, C. H.Annals of oncology. 2004, Vol 15, pp i35-i39, issn 0923-7534, SUP1Article

Ethical implications of predictive DNA testing for hereditary breast cancerDI PIETRO, M. L; GIULI, A; SPAGNOLO, A. G et al.Annals of oncology. 2004, Vol 15, pp 65-70, issn 0923-7534, 6 p., SUP1Article

Metastatic site and P53 primary tumor expression in previously untreated stage IV breast cancer patientsPARADISO, A; TOMMASI, S; DE LENA, M et al.Anticancer research. 1999, Vol 19, Num 5C, pp 4523-4528, issn 0250-7005Article

Analysis of clonal antigen receptor gene rearrangements in T-cells involved with Kaposi's sarcomaALAIBAC, M; CONGEDO, M; BARBAROSSA, G et al.Anticancer research. 1997, Vol 17, Num 2A, pp 1205-1207, issn 0250-7005Article

Comparison of formalin, ethanol, and histochoice fixation on the PCR amplification from paraffin-embedded breast cancer tissueGIANNELLA, C; ZITO, F. A; COLONNA, F et al.European journal of clinical chemistry and clinical biochemistry. 1997, Vol 35, Num 8, pp 633-635, issn 0939-4974Article

An overview of the status of imaging screening technology for breast cancerSMITH, J. A; ANDREOPOULOU, E.Annals of oncology. 2004, Vol 15, pp i18-i26, issn 0923-7534, SUP1Article

Failure of primary breast cancer neoangiogenesis to predict pattern of distant metastasisPARADISO, A; RANIERI, G; DE LENA, M et al.Clinical and experimental medicine (Testo stampato). 2001, Vol 1, Num 3, pp 127-132, issn 1591-8890, 6 p.Article

Cytosolic levels of estrogen-regulated pS2 protein in breast cancer: correlation with tumor proliferative activityCORREALE, M; PARADISO, A; ABBATE, I et al.Tumor biology. 1993, Vol 14, Num 1, pp 30-37, issn 1010-4283Article

HER-2/neu gene in primary and local metastatic axillary lymph nodes in human breast tumorsTOMMASI, S; GIANNELLA, C; DE LENA, M et al.The International journal of biological markers. 1992, Vol 7, Num 2, pp 107-113, issn 0393-6155Article

MMP-2, MMP-9, VEGF and CA 15.3 in breast cancerQUARANTA, M; DANIELE, A; SCHITTULLI, F et al.Anticancer research. 2007, Vol 27, Num 5B, pp 3593-3600, issn 0250-7005, 8 p.Article

External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 yearsMUELLER, C. R; KRISTOFFERSSON, U; STOPPA-LYONNET, D et al.Annals of oncology. 2004, Vol 15, pp i14-i17, issn 0923-7534, SUP1Article

Reducing breast cancer incidence in familial breast cancer: overlooking the present panoramaMARCHETTI, P; DI ROCCO, C. Z; RICEVUTO, E et al.Annals of oncology. 2004, Vol 15, pp i27-i34, issn 0923-7534, SUP1Article

Phase I/II study of gemcitabine plus mitoxantrone as salvage chemotherapy in metastatic breast cancerLORUSSO, V; CRUCITTA, E; SCHITTULLI, F et al.British journal of cancer. 2003, Vol 88, Num 4, pp 491-495, issn 0007-0920, 5 p.Article

GnRH receptors in human breast cancer and its contiguous not-involved breast tissuePARADISO, A; PEZZETTA, A; CELLAMARE, G et al.Journal of endocrinological investigation (Testo stampato). 2000, Vol 23, Num 2, pp 90-96, issn 0391-4097Article

A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 studyVICI, P; BRANDI, M; BENEDETTO, A. Di et al.Annals of oncology. 2012, Vol 23, Num 5, pp 1121-1129, issn 0923-7534, 9 p.Article

Genetic alterations in hereditary breast cancerCIPOLLINI, G; TOMMASI, S; TANCREDI, M et al.Annals of oncology. 2004, Vol 15, pp i7-i13, issn 0923-7534, SUP1Article